Explore how to analyze and interpret your own single-cell RNA-seq (scRNA-seq) data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA). In this 90-minute training, you’ll learn how to: • Start with FASTQ, cell matrix file and/or differential expression file for scRNA-seq data • Either automate or customize your analysis pipeline/workflow, depending on […]
QIAGEN CLC LightSpeed Module delivers an ultra-fast, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming, adapter trimming, read mapping, deduplication, local realignment, QC and germline variant calling. More details: https://qiagen.showpad.com/share/Tue4ZxKsjAFetyoswbTfE Cloud module: QIAGEN CLC Genomics Cloud computing software allows you […]
In this training, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more. In this training, you’ll […]
We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of […]
You may not have a typical transcriptomics dataset (i.e., a list of genes with differential expression), yet, you’d like to analyze a list of IDs. In this training, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA. Examples of lists that we’ll explore include: • A gene/protein/metabolite […]
We are excited to bring thought leaders, NGS experts, lab directors, variant scientists, clinicians, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18, 2023. The two-part, content-rich event will feature invited lectures from lab directors and clinical geneticists, thought-provoking discussions on the future of […]
In this 90-minute training session, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways, diseases, biological functions, tissues and cell types. We’ll cover topics such as: - How to analyze miRNA-seq datasets alone, or both miRNA and corresponding mRNA datasets together - How to use QIAGEN […]
Dentro de las aplicaciones oncológicas, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. Una nueva base de datos desarrollada por QIAGEN, la HSMD, contiene más de 2 décadas de contenido curado por expertos y datos de la QIAGEN Knowledge Base con más de […]
In 2023, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements, impediments removal and common goals. About changing attitudes, ways of working and minds. We want to hear stories of failure or win, standing up against change or championing it. What you […]
If you're a data scientist or bioinformatician working in biopharma, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft API provides a powerful and flexible platform for easy data discovery, retrieval, filtering, analysis and visualization. In this webinar, you'll learn how to leverage the […]
Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar, you will: Learn more about each workflow component. Hear from experts in the field as they discuss how this technology advances the diagnosis and management of inherited diseases. Examine real-world case studies demonstrating the clinical utility and cost-effectiveness of […]
You asked for it by popular demand, and we’re here to deliver. In this training, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST). In this training, we’ll cover: • Introduction to AMR, MLST and relevant databases • QIAGEN Microbial […]
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
